Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity
Malgorzata Wachowska1, Angelika Muchowicz1, Jakub Golab1
1Department of Immunology, Medical University of Warsaw , Warsaw , Poland.
Frontiers in Oncology
|August 19, 2015
Summary
Photodynamic therapy (PDT) combined with epigenetic treatments can overcome tumor immune evasion. This approach restores tumor antigen presentation, enhancing antitumor immunity and therapeutic effects.
Area of Science:
- Oncology
- Immunology
- Epigenetics
Background:
- Photodynamic therapy (PDT) induces cancer cell death and inflammation, releasing damage-associated molecular patterns (DAMPs) that can prime anti-tumor immune responses.
- Tumor cells often evade immune recognition through mechanisms like epigenetic silencing of tumor-associated antigens (TAA) and MHC molecules.
- Combining PDT with immunotherapies is a promising strategy to overcome immune evasion and induce systemic anti-tumor immunity.
Purpose of the Study:
- To review the immunoregulatory mechanisms of epigenetic treatments in conjunction with PDT.
- To discuss how epigenetic therapies can restore the expression of silenced TAAs and major histocompatibility complex (MHC) molecules.
- To present findings on the combination of PDT with methyltransferase inhibitors for enhanced anti-tumor immunity.
Main Methods:
- Review of existing literature on PDT, epigenetic modifications, and cancer immunotherapy.
- Analysis of studies investigating the restoration of TAA and MHC expression via epigenetic modulation.
- Evaluation of preclinical data on the combination of PDT with methyltransferase inhibitors.
Main Results:
- Epigenetic treatments can reverse the silencing of TAAs and MHC molecules, improving antigen presentation.
- The combination of PDT with methyltransferase inhibitors has demonstrated the ability to activate potent anti-tumor immune responses.
- Enhanced anti-tumor effects and the development of systemic immunity were observed in studies combining PDT and epigenetic therapies.
Conclusions:
- Epigenetic therapies hold significant potential for enhancing the efficacy of PDT by overcoming tumor immune escape mechanisms.
- Combining PDT with epigenetic agents, such as methyltransferase inhibitors, represents a viable strategy for generating robust and durable anti-tumor immunity.
- This combined approach offers a promising avenue for improving cancer treatment outcomes by harnessing the immune system.
Related Concept Videos
01:27Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:27Cytotoxic T Cells-mediated Immune Response
8.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K